Apollomics Inc.
APLM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001944885
In the last 90 days, Apollomics Inc. insiders filed 3 open-market purchases and 0 sales; 4 institutions reported holding it in 13F filings for Q2 2026, worth $223.8K in total; no superinvestor holds it.
Other share classesAPLMW
13F holders, Q1 2024
Institutional positions in Apollomics Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 12
- −1 vs. Q4 2023
- Shares held
- 9.25M
- +397.4K (+4.5%) vs. Q4 2023
- Total value
- $6.94M
- −$1.60M (−18.8%) vs. Q4 2023
- New holders
- 3
- 1 more added
- Sold out
- 4
- 2 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting APLM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 4 | $223.8K |
| Q1 2026 | 4 | $9.22K |
| Q4 2025 | 4 | $83.3K |
| Q3 2025 | 4 | $1.58K |
| Q2 2025 | 4 | $48.2K |
| Q1 2025 | 4 | $14.9K |
| Q4 2024 | 5 | $129.0K |
| Q3 2024 | 11 | $323.1K |
| Q2 2024 | 10 | $2.11M |
| Q1 2024 | 12 | $6.94M |
| Q4 2023 | 13 | $8.54M |
| Q3 2023 | 10 | $67.8M |
| Q2 2023 | 8 | $8.06M |
| Q1 2023 | 8 | $33.1M |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Apollomics Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| OrbiMed Advisors LLC | 8,565,456 | $6.42M | 0.13% | 00.0% | Unchanged |
| Exchange Traded Concepts, LLC | 387,609 | $290.7K | 0.01% | +351,936+986.6% | Added |
| Powell Investment Advisors, LLC | 130,297 | $97.7K | 0.05% | +130,297 | New |
| Geode Capital Management, LLC | 57,224 | $42.9K | 0.00% | 00.0% | Unchanged |
| Bensler, LLC | 25,088 | $18.8K | 0.00% | 00.0% | Unchanged |
| George Kaiser Family Foundation | 24,984 | $18.7K | 0.00% | 00.0% | Unchanged |
| Commonwealth Equity Services, LLC | 20,000 | $15.0K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 19,072 | $14.3K | 0.00% | +19,072 | New |
| Warberg Asset Management LLC | 10,026 | $7.32K | 0.00% | +10,026 | New |
| UBS Group AG | 7,512 | $5.63K | 0.00% | −24,624−76.6% | Reduced |
| Advisor Group Holdings, Inc. | 200 | $150 | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 86 | $65 | 0.00% | −6,476−98.7% | Reduced |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −54,722−100.0% | Sold out |
| Zullo Investment Group, Inc. | 0 | $0 | 0.00% | −14,853−100.0% | Sold out |
| Johnson & Johnson | 0 | $0 | 0.00% | −13,252−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −13−100.0% | Sold out |